---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-002087"
form_type: "8-K"
ticker: "EVFM"
cik: "0001618835"
company_name: "Evofem Biosciences, Inc."
filed_at: "2024-01-11T23:59:59+00:00"
generated_at: "2026-06-07T00:33:47.067798+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Evofem and Aditxt extend proxy filing deadline to Feb. 14, 2024 via first amendment to merger agreement

## Summary
- First Amendment to Merger Agreement moves Joint Proxy Statement filing date to February 14, 2024.
- No other terms of the December 11, 2023 merger agreement were changed.
- Merger Sub (Adicure) will merge into Evofem, with Evofem surviving as a wholly-owned subsidiary of Aditxt.

## SEC filing metadata
- accession: 0001493152-24-002087
- form_type: 8-K
- ticker: EVFM
- cik: 0001618835
- company_name: Evofem Biosciences, Inc.
- filed_at: 2024-01-11T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1618835/000149315224002087/0001493152-24-002087-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1618835/000149315224002087/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-002087
- JSON: https://secwatch.observer/filing/0001493152-24-002087.json
- Plain text: https://secwatch.observer/filing/0001493152-24-002087.txt

## Key facts
- Material Agreements
  Evofem Biosciences, Inc. amended Agreement and Plan of Merger with Aditxt, Inc., Adicure, Inc. (effective 2024-01-08).
  - Action: amendment
  - Agreement: merger
  - Counterparty: Aditxt, Inc., Adicure, Inc.
  - Effective: 2024-01-08
  source text: On January 8, 2024, the Company, Aditxt and Merger Sub entered into the first amendment to the Merger Agreement (the “First Amendment”), to change the filing date for the Joint Proxy Statement (as defined in the Merger Agreement) to February 14, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1618835/000149315224002087/0001493152-24-002087-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.